T. R. Sterling

Drug Transporter and Metabolizing Enzyme Gene Variants and Nonnucleoside Reverse-Transcriptase Inhibitor Hepatotoxicity

Marylyn D. Ritchie, David W. Haas, Alison A. Motsinger‐Reif et al. · Clinical Infectious Diseases · 2006 · 100 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting

April C. Pettit, Lisa A. Kaltenbach, Fernanda Maruri et al. · The International Journal of Tuberculosis and Lung Disease · 2011 · 39 citations

Public Health, Infectious Disease Control, Infectious Diseases +17

Risk Factors for Tuberculosis After Highly Active Antiretroviral Therapy Initiation in the United States and Canada: Implications for Tuberculosis Screening

T. R. Sterling, Bryan Lau, Jing Zhang et al. · The Journal of Infectious Diseases · 2011 · 37 citations · Full text

Public Health, Infectious Diseases, Preventive Medicine +17

Body mass index and early <scp>CD</scp>4 <scp>T</scp>‐cell recovery among adults initiating antiretroviral therapy in <scp>N</scp>orth <scp>A</scp>merica, 1998–2010

JR Koethe, CA Jenkins, Brandyn Lau et al. · HIV Medicine · 2015 · 34 citations · Full text

Public Health, Immunology, Clinical Immunology +12

Evaluation of an extensive tuberculosis contact investigation in an urban community and jail.

Sarah Bur, J. E. Golub, John A. Armstrong et al. · PubMed · 2003 · 26 citations

Public Health, Infectious Diseases, Infectious Disease Epidemiology +16